Albany, NY -- (SBWIRE) -- 07/03/2014 -- Soricimed Biopharma Inc. (Soricimed), formerly BioProspecting NB Inc. is a drug development company. The company carries out the development and commercialization of therapeutic and diagnostic programs. Its products under clinical development include SOR-C13, SO-C27, SOR-N54, SOR-D01, and SOR-D02. Soricimeds products are used in the treatment of ovarian, breast and prostate cancer, and other cancer types. The company also provides pain management technology. It partners with The Company and the Atlantic Cancer Research Institute, and BC Cancer Agency. The company has a service research agreement with NRC institutions including the NRC Institute for Biological Sciences, NRC Institute for Marine Biosciences, and the NRC Institute for Biodiagnostics. Soricimed is headquartered in Moncton, New Brunswick, Canada.
Browse more details @ http://www.researchmoz.us/soricimed-biopharma-inc-product-pipeline-analysis-2014-update-report.html
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Soricimed Biopharma Inc.
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Browse Latest Research Report @ http://www.researchmoz.us/latest-report.html
ResearchMoz.us features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The ResearchMoz.us team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and Corporate service for large organizations.
For more information kindly contact: